Characterizing and Predicting Drug Effects on Cognition
NCT01889602
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Cognitive Deficits
Interventions
DRUG:
Lorazepam
OTHER:
Placebo
DRUG:
Topiramate 100mg
DRUG:
Topiramate 150mg
DRUG:
Topiramate 200mg
Sponsor
University of Minnesota